On July 16, 2021, AbbVie, Inc., submitted a notification of proposed production activity to the FTZ Board for its facilities within Subzone 22S, in North Chicago and Lake County, Illinois.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (86 FR 41008, July 30, 2021). On November 15, 2021, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.
Dated: November 15, 2021.
Camille Evans,
Acting Executive Secretary.
[FR Doc. 2021-25186 Filed 11-17-21; 8:45 am]
BILLING CODE 3510-DS-P